[go: up one dir, main page]

AR059619A1 - Derivados halogenados de sulfonamidas - Google Patents

Derivados halogenados de sulfonamidas

Info

Publication number
AR059619A1
AR059619A1 ARP070100766A ARP070100766A AR059619A1 AR 059619 A1 AR059619 A1 AR 059619A1 AR P070100766 A ARP070100766 A AR P070100766A AR P070100766 A ARP070100766 A AR P070100766A AR 059619 A1 AR059619 A1 AR 059619A1
Authority
AR
Argentina
Prior art keywords
pyridyl
hulogenated
sulfonamids
derivatives
inclusive
Prior art date
Application number
ARP070100766A
Other languages
English (en)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of AR059619A1 publication Critical patent/AR059619A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)

Abstract

Reivindicacion 1: Un compuesto que presenta la estructura (1) donde R1 es H o alquilo C1-6 de cadena recta o ramificada; donde R2 es alquilo C1-6 de cadena recta o ramificada; o donde R1, R2 y el carbono al que están unidos pueden formar cicloalquilo C3-6; donde R3 H o metilo; donde R4 es 2-piridilo o 3-piridilo, donde el 2-piridilo o 3-piridilo está sustituido con uno o más F, CI, Br, I o CF3 y de modo opcional está sustituido con CH3; donde R5 es H o metilo; donde m es un numero entero de 0 a 2 inclusive; y donde n es un numero entero de 0 a 2 inclusive; o una sal aceptable para uso farmacéutico.
ARP070100766A 2006-03-07 2007-02-23 Derivados halogenados de sulfonamidas AR059619A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77976506P 2006-03-07 2006-03-07
US87832707P 2007-01-03 2007-01-03

Publications (1)

Publication Number Publication Date
AR059619A1 true AR059619A1 (es) 2008-04-16

Family

ID=38475459

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070100766A AR059619A1 (es) 2006-03-07 2007-02-23 Derivados halogenados de sulfonamidas

Country Status (4)

Country Link
US (1) US20070213376A1 (es)
AR (1) AR059619A1 (es)
TW (1) TW200800979A (es)
WO (1) WO2007103295A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2650683A1 (en) * 2006-04-28 2007-11-08 Shionogi & Co., Ltd. Amine derivative having npy y5 receptor antagonist activity
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
SA08290668B1 (ar) 2007-10-25 2012-02-12 شيونوجي آند كو.، ليمتد مشتقات أمين لها نشاط مضاد لمستقبل npy y5 واستخداماتها
US8227618B2 (en) 2009-04-23 2012-07-24 Shionogi & Co., Ltd. Amine-derivatives having NPY Y5 receptor antagonistic activity and the uses thereof
EP2582709B1 (de) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
WO2012120056A1 (de) 2011-03-08 2012-09-13 Sanofi Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8901114B2 (en) 2011-03-08 2014-12-02 Sanofi Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
EP2683705B1 (de) 2011-03-08 2015-04-22 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683699B1 (de) 2011-03-08 2015-06-24 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120053A1 (de) 2011-03-08 2012-09-13 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
CA2834429C (en) 2011-04-27 2019-07-02 Kyohei Hayashi 5-membered ring aromatic heterocyclic derivative having npy y5 receptor antagonistic activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6989379B1 (en) * 1999-04-22 2006-01-24 H. Lundbick A/S Selective NPY (Y5) antagonists
US6218408B1 (en) * 1999-06-30 2001-04-17 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
US6214853B1 (en) * 1999-06-30 2001-04-10 Synaptic Pharmaceutical Corporation Selective NPY (Y5) antagonists (bicyclics)
HUP0302969A3 (en) * 1999-11-26 2005-05-30 Shionogi & Co Npyy5 antagonists, pharmaceutical compositions containing them and their use
US20060293341A1 (en) * 2005-06-23 2006-12-28 Vrej Jubian Alkyl sulfonamide derivatives

Also Published As

Publication number Publication date
TW200800979A (en) 2008-01-01
US20070213376A1 (en) 2007-09-13
WO2007103295A2 (en) 2007-09-13
WO2007103295A3 (en) 2007-12-13

Similar Documents

Publication Publication Date Title
AR059619A1 (es) Derivados halogenados de sulfonamidas
AR061134A1 (es) Derivados de tioxantina
CY1110034T1 (el) Παραγωγα 1,2,4,5-τετραϋδρο-3h-βενζαζεπινων, μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν
AR106944A2 (es) Compuestos de isoindolina y composiciones farmacéuticas de los mismos
CO6321248A2 (es) Derivados de triazol utiles para el tratamiento de enfermedades
AR110128A2 (es) Compuesto del grupo de las 3-(imidazoil)-pirazolo[3,4-b]piridinas, composición farmacéutica que lo comprende y método para preparar el mismo
AR061980A1 (es) Acilanilidas sustituidas y metodos para su utilizacion
CR10034A (es) Derivados de oxadiazol
UY31736A (es) Derivados sustituidos de pirazol y su uso
CY1113011T1 (el) Νεα κρυσταλλικη μορφη v της αγομελατινης, μεθοδος παρασκευης αυτης και φαρμακευτικες συνθεσεις που περιεχουν αυτην
CO6382079A2 (es) Composiciones insecticidas estables a base de sulfoximina
CO6230986A2 (es) Compuesto de 4-piridinona y su uso para cancer
AR062677A1 (es) Derivados de biaril-sulfonamida, procesos de produccion y composiciones farmaceuticas que los comprenden
UY31774A (es) Compuestos de 2-pirimidin-5- ilcarboxamida sustituidos
CL2008002295A1 (es) Compuestos derivados de tiazolida sustituidos con alquilsulfonilos; composicion farmaceutica; y uso para el tratamiento de la hepatitis c.
EA201201178A1 (ru) Пестицидные смеси, включающие изоксазолиновые производные и инсектицид или нематоцидное биологическое средство
AR081058A1 (es) Derivados de arilmetoxi isoindolina, composiciones que los comprenden y su uso en el tratamiento del cancer.
BRPI0719393B8 (pt) composição farmacêutica
AR062797A1 (es) Derivados de piperidina como inhibidores de renina, composiciones farmaceuticas.
AR076024A1 (es) Derivados de heterociclos biciclicos puenteados y metodos de uso de los mismos
AR062211A1 (es) Derivados de 6-carboxi-normorfinano. composiciones farmaceuticas
NO20075734L (no) Tiofenforbindelser og trombopoietin reseptoractivatorer
EA201070839A1 (ru) Новые производные ацилцианопирролидинов
AR081725A1 (es) Derivados de oxadiazol, proceso de preparacion de los mismos, composicion farmaceutica que los contienen y su uso en el tratamiento del cancer
CY1115623T1 (el) Μεθοδος για την συνθεση 7,8-διμεθοξυ-1,3-διϋδρο-2η-3-βενζαζεπιν-2-ονης και εφαρμογη αυτης στη συνθεση της ιβαμπραδινης καθως επισης αλατων προσθηκης αυτης με ενα φαρμακευτικως αποδεκτο οξυ

Legal Events

Date Code Title Description
FA Abandonment or withdrawal